Cytokinetics
CYTK
#2295
Rank
โ‚ฌ6.76 B
Marketcap
54,90ย โ‚ฌ
Share price
0.75%
Change (1 day)
47.80%
Change (1 year)

Revenue for Cytokinetics (CYTK)

Revenue in 2025 (TTM): โ‚ฌ74.86 Million

According to Cytokinetics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ76.76 Million. an increase over the revenue in the year 2024 that were of โ‚ฌ17.75 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cytokinetics from 2003 to 2025

Annual revenue

Year Revenue Change
2025 โ‚ฌ74.94 M322.15%
2024 โ‚ฌ17.75 M160.63%
2023 โ‚ฌ6.81 M-92.28%
2022 โ‚ฌ88.17 M41.8%
2021 โ‚ฌ62.18 M37.01%
2020 โ‚ฌ45.38 M89.24%
2019 โ‚ฌ23.98 M-12.9%
2018 โ‚ฌ27.53 M147.15%
2017 โ‚ฌ11.14 M-88.99%
2016 โ‚ฌ0.10 B285.97%
2015 โ‚ฌ26.21 M-32.09%
2014 โ‚ฌ38.59 M73.91%
2013 โ‚ฌ22.19 M288.35%
2012 โ‚ฌ5.71 M85.53%
2011 โ‚ฌ3.08 M59.04%
2010 โ‚ฌ1.93 M-96.6%
2009 โ‚ฌ56.91 M540.59%
2008 โ‚ฌ8.88 M-4.77%
2007 โ‚ฌ9.32 M293.67%
2006 โ‚ฌ2.36 M-68.5%
2005 โ‚ฌ7.52 M-24.08%
2004 โ‚ฌ9.9 M17.8%
2003 โ‚ฌ8.41 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
โ‚ฌ32.04 B 41,644.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
โ‚ฌ0.47 M-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ0.23 B 204.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
โ‚ฌ0.10 B 31.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
โ‚ฌ1.16 B 1,414.48%๐Ÿ‡บ๐Ÿ‡ธ USA